1. Sunitinib
   Giuseppe Tridente, 2017, Adverse Events and Oncotargeted Kinase Inhibitors CrossRef
2. Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice
   Margherita Nannini et al, 2017, Therapeutic Advances in Medical Oncology CrossRef
3. Personalized Medicine in Gastrointestinal Stromal Tumors
   Margherita Nannini et al, 2019, Oncogenomics CrossRef
4. Population Pharmacokinetic/Pharmacodynamic Modeling of Sunitinib by Dosing Schedule in Patients with Advanced Renal Cell Carcinoma or Gastrointestinal Stromal Tumor
   Reza Khosravan et al, 2016, Clinical Pharmacokinetics CrossRef
5. Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors
   Maristella Saponara et al, 2016, Anti-Cancer Drugs CrossRef
6. English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology
   Seiichi Hirota et al, 2024, International Journal of Clinical Oncology CrossRef